Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Regeneron Pharmaceuticals, Inc.

NASDAQ: REGN · Life Sciences · 13 alerts · CIK 872589

Share price
$952.40Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Regeneron Pharmaceuticals, Inc. filings on SEC EDGAR ↗

7:52 AM ET 8-K
Research Collaboration

Regeneron Pharmaceuticals Research Collaboration with Sanofi Worth $1B

Regeneron and Sanofi entered into a Sixth Amendment to their existing Antibody LCA to co-develop and co-commercialize four new long-acting antibodies targeting IL-13, IL-4, and IL-4Rα. Sanofi will pay Regeneron an upfront payment of $1.0 billion and up to $7.0 billion in potential development, regulatory, and commercial milestones, with global profits and development costs shared equally.

Value
$1B
Counterparty
Sanofi

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.